Literature DB >> 7922063

Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery.

D M Baker1, J A Jones, J S Nguyen-Van-Tam, J H Lloyd, D L Morris, J B Bourke, R J Steele, J D Hardcastle.   

Abstract

A total of 300 patients undergoing elective colorectal surgery over a 3-year period were randomly assigned to receive intraoperative peritoneal lavage with either taurolidine or saline. Culture swabs were taken from the region of surgery before and after lavage and the development of postoperative infection monitored. Of the positive culture swabs before lavage, a significantly higher proportion were negative after lavage with taurolidine than after that with saline. However, there was no difference in the incidence of postoperative infection between groups, suggesting that taurolidine intraoperative peritoneal lavage confers no clinical benefit over that with saline.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7922063     DOI: 10.1002/bjs.1800810743

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

Review 1.  Intracavity lavage and wound irrigation for prevention of surgical site infection.

Authors:  Gill Norman; Ross A Atkinson; Tanya A Smith; Ceri Rowlands; Amber D Rithalia; Emma J Crosbie; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

2.  Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.

Authors:  Ansgar M Chromik; Adrien Daigeler; Daniel Bulut; Annegret Flier; Christina May; Kamran Harati; Jan Roschinsky; Dominique Sülberg; Peter R Ritter; Ulrich Mittelkötter; Stephan A Hahn; Waldemar Uhl
Journal:  J Exp Clin Cancer Res       Date:  2010-03-07

3.  Taurolidine as an effective and biocompatible additive for plaque-removing techniques on implant surfaces.

Authors:  Gordon John; Frank Schwarz; Jürgen Becker
Journal:  Clin Oral Investig       Date:  2014-10-28       Impact factor: 3.573

4.  Activities of taurolidine in vitro and in experimental enterococcal endocarditis.

Authors:  C Torres-Viera; C Thauvin-Eliopoulos; M Souli; P DeGirolami; M G Farris; C B Wennersten; R D Sofia; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

5.  Co-immunotherapy with interleukin-2 and taurolidine for progressive metastatic melanoma.

Authors:  G C O'Brien; R A Cahill; D J Bouchier-Hayes; H P Redmond
Journal:  Ir J Med Sci       Date:  2006 Jan-Mar       Impact factor: 1.568

6.  Autophagy induced by taurolidine protects against polymicrobial sepsis by promoting both host resistance and disease tolerance.

Authors:  Jie Huang; Michael Ita; Huiting Zhou; He Zhao; Fara Hassan; Zhenjiang Bai; D Peter O'Leary; Yiping Li; H Paul Redmond; Jiang Huai Wang; Jian Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-05       Impact factor: 12.779

7.  Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia.

Authors:  Helge Frieling; Kai-Steffen Lauer; Matthias Gründling; Taras Usichenko; Konrad Meissner; Theoni Kanellopoulou; Christian Lehmann; Michael Wendt; Dragan Pavlovic
Journal:  Int J Colorectal Dis       Date:  2006-11-21       Impact factor: 2.796

8.  Gene expression analysis of cell death induction by taurolidine in different malignant cell lines.

Authors:  Ansgar M Chromik; Stephan A Hahn; Adrien Daigeler; Annegret Flier; Daniel Bulut; Christina May; Kamran Harati; Jan Roschinsky; Dominique Sülberg; Dirk Weyhe; Ulrich Mittelkötter; Waldemar Uhl
Journal:  BMC Cancer       Date:  2010-10-30       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.